Abstract
α-Synuclein conformational modulation leading to fibrillation has been centrally implicated in Parkinson’s disease. Previously, we have shown that α-synuclein has DNA binding property. In the present study, we have characterized the effect of DNA binding on the conformation and fibrillation kinetics of α-synuclein. It was observed that single-stranded circular DNA induce α-helix conformation in α-synuclein while plasmid supercoiled DNA has dual effect inducing a partially folded conformation and α-helix under different experimental conditions. Interestingly, α-synuclein showed a specificity for GC* nucleotide sequence in its binding ability to DNA. The aggregation kinetics data showed that DNA which induced partially folded conformation in α-synuclein promoted the fibrillation while DNA which induced α-helix delayed the fibrillation, indicating that the partially folded intermediate conformation is critical in the aggregation process. Further, the mechanism of DNA-induced folding/aggregation of α-synuclein was studied using effect of osmolytes on α-synuclein as a model system. Among the five osmolytes used, Glycerol, trimethylamine- N-oxide, Betaine, and Taurine induced partially folded conformation and in turn enhanced the aggregation of α-synuclein. The ability of DNA and osmolytes in inducing conformational transition in α-synuclein, indicates that two factors are critical in modulating α-synuclein folding: (i) electrostatic interaction as in the case of DNA, and (ii) hydrophobic interactions as in the case of osmolytes. The property of DNA inducing α-helical conformation in α-synuclein and inhibiting the fibrillation may be of significance in engineering DNA-chip based therapeutic approaches to PD and other amyloid disorders.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call